MR编号 | AT/H/0586/001 |
---|
药品名称 | Bivalirudin Accord 250 mg powder for concentrate for solution for injection or infusion |
---|
活性成分 | |
---|
剂型 | Powder for concentrate for solution for infusion/injection |
---|
上市许可持有人 | Accord Healthcare B.V.
Winthontlaan 200,
3526KV Utrecht
Niederlande
ÜBER Accord Healthcare Lim., UK |
---|
参考成员国 - 产品名称 | Austria (AT) Bivalirudin Accord 250 mg Pulver für ein Konzentrat zur Herstellung einer Injektions- oder Infusions |
---|
互认成员国 - 产品名称 | - Germany (DE)
Bivalirudin Accord 250 mg Pulver z. H. e. Konz. f. e. Injektions - o. Infusionslösung - Belgium (BE)
Bivalirudin Accord Healthcare 250 mg poeder voor concentraat voor oplossing voor injectie of intrave - Netherlands (NL)
- United Kingdom (Northern Ireland) (XI)
- France (FR)
- Portugal (PT)
- Italy (IT)
- Poland (PL)
Biwalirudyna Accord - Slovenia (SI)
Bivalirudin Accord 250 mg prašek za koncentrat za raztopino za injiciranje ali infundiranje
|
---|
许可日期 | 2016/05/12 |
---|
最近更新日期 | 2024/11/25 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|